Supreme Court invalidates some gene patents but biotech has moved on

Sharon Begley | Reuters | June 18, 2013

The following is an edited excerpt.

The U.S. Supreme Court decision on June 13, 2013 to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn’t: the industry has already moved on.

Read the full story here: As top court invalidates some gene patents, biotech has moved on

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.